Additional file 5: of Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study TomitaYoshihiko UemuraHirotsugu OyaMototsugu ShinoharaNobuo HabuchiTomonori FujiiYosuke KameiYoichi UmeyamaYoshiko BairAngel RiniBrian 2019 Table presenting “Multivariate analysis of patient baseline characteristics for the effect of interaction with axitinib titration on OS.” (PDF 105 kb)